AN2 Therapeutics, Inc. (ANTX) Q3 2024 Earnings
ANTX·Reported November 13, 2024·Before market open
Diluted EPS came in at $-0.43, missed the $-0.37 consensus by $0.06.
Diluted EPS
$-0.43missed by $0.06
Consensus: $-0.37
Financial Snapshot
Trailing eight quarters through Q3 2024
Q3 2024 Earnings FAQ
Common questions about AN2 Therapeutics, Inc.'s Q3 2024 earnings report.
AN2 Therapeutics, Inc. (ANTX) reported Q3 2024 earnings on November 13, 2024 before market open.
AN2 Therapeutics, Inc. reported diluted EPS of $-0.43 for Q3 2024.
EPS missed the consensus estimate of $-0.37 by $0.06.
You can read the 10-Q periodic report (0000950170-24-126282) directly on SEC EDGAR. The filing index links above go to sec.gov.